GDC-0425 Uses, Dosage, Side Effects and more
GDC-0425 is under investigation in clinical trial NCT01359696 (A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma).
| Trade Name | GDC-0425 |
| Generic | GDC-0425 |
| Type | |
| Formula | C18H19N5O |
| Weight | Average: 321.384 Monoisotopic: 321.158960252 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
